GR79236 是一种高效,选择性和具有口服活性的腺苷 A1 受体 (adenosine A1 receptor) 激动剂,对于A1和 A2 受体的Ki值分别为 3.1 nM 和 1300 nM。GR79236 具有抗伤害和抗炎作用。
生物活性 | GR79236 is a highly potent, selective and orally activeadenosine A1 receptoragonist with aKis of 3.1 nM and 1300 nM forA1and A2 receptors, respectively. GR79236 has anti-nociceptive and anti-inflammatory actions[1][2]. |
IC50& Target | Ki: 3.1 nM (Adenosine A1 receptor) and 1300 nM (Adenosine A2 receptor)[1] |
体外研究 (In Vitro) | GR79236 inhibits Isoprenaline-stimulated cAMP accumulation in DDT-MF2 cells with an IC50of 2.6 nM[1]. GR79236 inhibits catecholamine-induced lipolysis in human, rat and dog isolated adipocytes[3].
|
体内研究 (In Vivo) | GR79236 decreases locomotor activity and inhibits DMCM-induced seizures in mice (ED50s of 0.13 mg/kg and 0.3 mg/kg, respectively)[1]. Oral administration of GR79236 (0.1-10 mg/kg) to fed rats induces minimal changes in the plasma concentration of non-esterified fatty acids and in the blood concentrations of glucose and lactate[3]. Intravenous infusion of GR79236 to fasted pithed rats, or oral administration of GR79236 to fasted conscious rats and dogs, produces time- and dose-dependent decreases in the plasma non-esterified fatty acid concentration. In the fasted rats, doses of GR79236 that lowered plasma levels of non-esterified fatty acids also produced hypotriglyceridaemia and anti-ketotic effects[3].
|
分子量 | |
性状 | |
Formula | |
CAS 号 | |
运输条件 | Room temperature in continental US; may vary elsewhere. |
储存方式 | Powder | -20°C | 3 years | | 4°C | 2 years | In solvent | -80°C | 6 months | | -20°C | 1 month |
|
溶解性数据 | In Vitro: H2O : 100 mg/mL(284.61 mM;Need ultrasonic) DMSO : ≥ 100 mg/mL(284.61 mM) *"≥" means soluble, but saturation unknown. 配制储备液 1 mM | 2.8461 mL | 14.2304 mL | 28.4608 mL | 5 mM | 0.5692 mL | 2.8461 mL | 5.6922 mL | 10 mM | 0.2846 mL | 1.4230 mL | 2.8461 mL |
*请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80℃, 6 months; -20℃, 1 month。-80℃ 储存时,请在 6 个月内使用,-20℃ 储存时,请在 1 个月内使用。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百 分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶 1. 请依序添加每种溶剂: PBS Solubility: 11.11 mg/mL (31.62 mM); Clear solution; Need ultrasonic and warming and heat to 60℃ 2. 请依序添加每种溶剂: 10% DMSO 40%PEG300 5%Tween-80 45% saline Solubility: ≥ 2.5 mg/mL (7.12 mM); Clear solution
此方案可获得 ≥ 2.5 mg/mL (7.12 mM,饱和度未知) 的澄清溶液。 以 1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中,混合均匀;向上述体系中加入50 μL Tween-80,混合均匀;然后继续加入 450 μL生理盐水定容至 1 mL。 3. 请依序添加每种溶剂: 10% DMSO 90% (20%SBE-β-CDin saline) Solubility: ≥ 2.5 mg/mL (7.12 mM); Clear solution
此方案可获得 ≥ 2.5 mg/mL (7.12 mM,饱和度未知) 的澄清溶液。 以 1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL20% 的 SBE-β-CD 生理盐水水溶液中,混合均匀。 4. 请依序添加每种溶剂: 10% DMSO 90%corn oil Solubility: ≥ 2.5 mg/mL (7.12 mM); Clear solution
此方案可获得 ≥ 2.5 mg/mL (7.12 mM,饱和度未知) 的澄清溶液,此方案不适用于实验周期在半个月以上的实验。 以 1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中,混合均匀。 *以上所有助溶剂都可在本网站选购。
|